VNDA

Vanda Pharmaceuticals Inc. News Headlines

$14.61
*  
0.30
 negative 
2.01%
Get VNDA Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VNDA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ANGO Sees Growth Ahead, DelMar On Track, HALO Loses Shine, VNDA In Launch Mode
4/10/2014 12:05:00 AM - RTT News

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape
3/14/2014 9:21:01 AM - Zacks.com

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High
2/21/2014 10:00:00 AM - Seeking Alpha

Vanda Reports Wider-than-Expected Loss - Analyst Blog
2/18/2014 12:30:01 PM - Zacks.com

Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming
2/11/2014 8:31:00 AM - Seeking Alpha

SA PRO: Top Long And Short Ideas, Monday February 10
2/11/2014 7:30:00 AM - Seeking Alpha

Forest Labs Fights Back, VNDA Gets Thumbs Up From FDA, IntelGenx Awaits Decision
2/3/2014 5:09:00 AM - RTT News

FDA Approves Vanda's Hetlioz To Treat Sleep Disorder In Fully Blind Individuals
2/1/2014 2:07:00 PM - RTT News

Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
1/2/2014 10:25:01 AM - Zacks.com

Peregrine Pharma Initiates Bavituximab Study - Analyst Blog
12/31/2013 6:20:01 PM - Zacks.com

Pipeline Setback at Can-Fite BioPharma, Shares Down - Analyst Blog
12/31/2013 12:50:01 PM - Zacks.com

Priority Review for CBST's Antibiotic - Analyst Blog
12/31/2013 12:40:01 PM - Zacks.com

Update on RedHill Biopharma's Pipeline - Analyst Blog
12/30/2013 7:30:01 PM - Zacks.com

Update on AstraZeneca's Crestor - Analyst Blog
12/30/2013 6:40:01 PM - Zacks.com

Post-TEVA Deal, ANIP Shares Rise - Analyst Blog
12/30/2013 5:37:01 PM - Zacks.com

Chelsea: FDA Panel Meeting And Trading Strategies
12/30/2013 4:34:00 PM - Seeking Alpha

Actavis' Women Health Biz Update - Analyst Blog
12/30/2013 3:51:01 PM - Zacks.com

Vanda Pharmaceuticals Inc. (VNDA) Shares March Higher, Can It Continue? - Tale of the Tape
12/30/2013 10:23:23 AM - Zacks.com

Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2
12/30/2013 8:01:00 AM - Seeking Alpha

Update on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog
12/27/2013 6:02:09 PM - Zacks.com

Pipeline Update on Aratana - Analyst Blog
12/27/2013 5:45:01 PM - Zacks.com

Pipeline Update on Santarus Candidate - Analyst Blog
12/26/2013 6:10:01 PM - Zacks.com

Update on ARIAD's Iclusig - Analyst Blog
12/26/2013 5:45:01 PM - Zacks.com

Pipeline Progress at Athersys - Analyst Blog
12/24/2013 6:17:44 PM - Zacks.com